Episode 76
Biotech Hangout
Marathi's Potential in the Market and Competition with Amgen
The chapter discusses Marathi's market potential for G12C drugs and their combination program, as well as the comparison to Amgen's strategy. The speakers highlight Marathi's PRM-T5 program and the use of CVR for valuation. They also discuss Amgen's data on this drug class.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
